Three Pt( ii ) complexes based on thiosemicarbazone: synthesis, HSA interaction, cytotoxicity, apoptosis and cell cycle arrest

Three thiosemicarbazone-based platinum(ii) complexes [Pt(MH-TSC)Cl] (1), [Pt(ME-TSC)Cl] (2) and [Pt(NH-TSC)2]Cl (3) (MH-TSC = (E)-2-(1-(pyridin-2-yl)ethylidene)hydrazinecarbothioamide, ME-TSC = (E)-N-ethyl-2-(1-(pyridin-2-yl)ethylidene) hydrazinecarbothioamide, NH-TSC = (Z)-2-(amino(pyridin-2-yl)met...

Full description

Saved in:
Bibliographic Details
Published inRSC advances Vol. 7; no. 42; pp. 26478 - 26486
Main Authors Lin, Xu-Dong, Liu, Ya-Hong, Xie, Cheng-Zhi, Bao, Wei-Guo, Shen, Jun, Xu, Jing-Yuan
Format Journal Article
LanguageEnglish
Published 01.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Three thiosemicarbazone-based platinum(ii) complexes [Pt(MH-TSC)Cl] (1), [Pt(ME-TSC)Cl] (2) and [Pt(NH-TSC)2]Cl (3) (MH-TSC = (E)-2-(1-(pyridin-2-yl)ethylidene)hydrazinecarbothioamide, ME-TSC = (E)-N-ethyl-2-(1-(pyridin-2-yl)ethylidene) hydrazinecarbothioamide, NH-TSC = (Z)-2-(amino(pyridin-2-yl)methylene)hydrazinecarbothioamide) were synthesized and structurally characterized. X-ray analyses revealed that 1 and 2 possessed similar a neutral mononuclear unit in which one tridentate TSC ligand and one leaving group (Cl-) coordinated to Pt(ii) ion, while 3 was cationic and formed by two NH-TSC ligands surrounding one Pt atom in a meridional arrangement. UV-visible and fluorescence spectra of human serum albumin (HSA) with the complexes displayed that the quenching mechanism of HSA by 1-3 might be a static binding mode. Moreover, synchronous fluorescence experiments proved that 1-3 affected the microenvironment of tryptophan residues of HSA. In addition, the antiproliferative activities against MCF-7 (human breast cancer lines), HepG-2 (human liver hepatocellular carcinoma cell line), NCI-H460 (non-small cell lung cancer lines) and HeLa (human epithelial cervical cancer cell line) were screened for 1-3. Inspiringly, their cytotoxic activity (IC50 = 1.7-9.6 mu M) appeared much better than that of cisplatin (IC50 = 5.2-13.5 mu M) against different cell lines, respectively. Among them, complex 3 exhibited the strongest inhibition on the viability of all tested cell lines with IC50 values of 1.7-2.2 mu M. Inductively-coupled plasma mass spectrometry (ICP-MS) showed that 3 accumulated rapidly in cells and reached intracellular levels of up to 10-fold higher than those determined for 1 and 2. Furthermore, fluorescence microscopic observation and flow cytometric analysis revealed that 1-3 could effectively induce apoptosis of HeLa cells, which were arrested in the S phase after treatment with 1 (30.31%) and 3 (46.96%), and in G2 phase with 2 (20.2%). All the results mentioned above suggest that complexes 1-3 might be efficient antitumor agents.
AbstractList Three thiosemicarbazone-based platinum( ii ) complexes [Pt(MH-TSC)Cl] ( 1 ), [Pt(ME-TSC)Cl] ( 2 ) and [Pt(NH-TSC) 2 ]Cl ( 3 ) (MH-TSC = ( E )-2-(1-(pyridin-2-yl)ethylidene)hydrazinecarbothioamide, ME-TSC = ( E )- N -ethyl-2-(1-(pyridin-2-yl)ethylidene) hydrazinecarbothioamide, NH-TSC = ( Z )-2-(amino(pyridin-2-yl)methylene)hydrazinecarbothioamide) were synthesized and structurally characterized. X-ray analyses revealed that 1 and 2 possessed similar a neutral mononuclear unit in which one tridentate TSC ligand and one leaving group (Cl − ) coordinated to Pt( ii ) ion, while 3 was cationic and formed by two NH-TSC ligands surrounding one Pt atom in a meridional arrangement. UV-visible and fluorescence spectra of human serum albumin (HSA) with the complexes displayed that the quenching mechanism of HSA by 1–3 might be a static binding mode. Moreover, synchronous fluorescence experiments proved that 1–3 affected the microenvironment of tryptophan residues of HSA. In addition, the antiproliferative activities against MCF-7 (human breast cancer lines), HepG-2 (human liver hepatocellular carcinoma cell line), NCI-H460 (non-small cell lung cancer lines) and HeLa (human epithelial cervical cancer cell line) were screened for 1–3 . Inspiringly, their cytotoxic activity (IC 50 = 1.7–9.6 μM) appeared much better than that of cisplatin (IC 50 = 5.2–13.5 μM) against different cell lines, respectively. Among them, complex 3 exhibited the strongest inhibition on the viability of all tested cell lines with IC 50 values of 1.7–2.2 μM. Inductively-coupled plasma mass spectrometry (ICP-MS) showed that 3 accumulated rapidly in cells and reached intracellular levels of up to 10-fold higher than those determined for 1 and 2 . Furthermore, fluorescence microscopic observation and flow cytometric analysis revealed that 1–3 could effectively induce apoptosis of HeLa cells, which were arrested in the S phase after treatment with 1 (30.31%) and 3 (46.96%), and in G2 phase with 2 (20.2%). All the results mentioned above suggest that complexes 1–3 might be efficient antitumor agents.
Three thiosemicarbazone-based platinum(ii) complexes [Pt(MH-TSC)Cl] (1), [Pt(ME-TSC)Cl] (2) and [Pt(NH-TSC)2]Cl (3) (MH-TSC = (E)-2-(1-(pyridin-2-yl)ethylidene)hydrazinecarbothioamide, ME-TSC = (E)-N-ethyl-2-(1-(pyridin-2-yl)ethylidene) hydrazinecarbothioamide, NH-TSC = (Z)-2-(amino(pyridin-2-yl)methylene)hydrazinecarbothioamide) were synthesized and structurally characterized. X-ray analyses revealed that 1 and 2 possessed similar a neutral mononuclear unit in which one tridentate TSC ligand and one leaving group (Cl-) coordinated to Pt(ii) ion, while 3 was cationic and formed by two NH-TSC ligands surrounding one Pt atom in a meridional arrangement. UV-visible and fluorescence spectra of human serum albumin (HSA) with the complexes displayed that the quenching mechanism of HSA by 1-3 might be a static binding mode. Moreover, synchronous fluorescence experiments proved that 1-3 affected the microenvironment of tryptophan residues of HSA. In addition, the antiproliferative activities against MCF-7 (human breast cancer lines), HepG-2 (human liver hepatocellular carcinoma cell line), NCI-H460 (non-small cell lung cancer lines) and HeLa (human epithelial cervical cancer cell line) were screened for 1-3. Inspiringly, their cytotoxic activity (IC50 = 1.7-9.6 mu M) appeared much better than that of cisplatin (IC50 = 5.2-13.5 mu M) against different cell lines, respectively. Among them, complex 3 exhibited the strongest inhibition on the viability of all tested cell lines with IC50 values of 1.7-2.2 mu M. Inductively-coupled plasma mass spectrometry (ICP-MS) showed that 3 accumulated rapidly in cells and reached intracellular levels of up to 10-fold higher than those determined for 1 and 2. Furthermore, fluorescence microscopic observation and flow cytometric analysis revealed that 1-3 could effectively induce apoptosis of HeLa cells, which were arrested in the S phase after treatment with 1 (30.31%) and 3 (46.96%), and in G2 phase with 2 (20.2%). All the results mentioned above suggest that complexes 1-3 might be efficient antitumor agents.
Author Lin, Xu-Dong
Liu, Ya-Hong
Shen, Jun
Xie, Cheng-Zhi
Bao, Wei-Guo
Xu, Jing-Yuan
Author_xml – sequence: 1
  givenname: Xu-Dong
  surname: Lin
  fullname: Lin, Xu-Dong
– sequence: 2
  givenname: Ya-Hong
  surname: Liu
  fullname: Liu, Ya-Hong
– sequence: 3
  givenname: Cheng-Zhi
  surname: Xie
  fullname: Xie, Cheng-Zhi
– sequence: 4
  givenname: Wei-Guo
  surname: Bao
  fullname: Bao, Wei-Guo
– sequence: 5
  givenname: Jun
  surname: Shen
  fullname: Shen, Jun
– sequence: 6
  givenname: Jing-Yuan
  surname: Xu
  fullname: Xu, Jing-Yuan
BookMark eNqNkcFLwzAUxoNMcM5d_AtynLJqkqZp420M3YSBovNc0uxti7RNTTJYPfi32zkPHn2X9_j48b4PvnPUq20NCF1SckNJLG916hThnMebE9RnhIuIESF7f-4zNPT-nXQjEsoE7aOv5dYB4OcwwsbgK6xt1ZSwB48L5WGFbY3D1lgPldHKFeqzs7zDvq3DFrzxYzx_nWBTB3BKB2PrMdZtsMHujTahHWPV2CbYjsSqXmENZdkBugSsnAMfLtDpWpUehr97gN4e7pfTebR4mj1OJ4tIM55tIsZWILWg64xQYEzqQkHCC4hjWsg0ISmnQLJEJ4pKArFIsoJR3umSdzql8QCNjn8bZz92nXFeGX9Io2qwO59TSZOYsTRl_0CJ4IkUWdah10dUO-u9g3XeOFMp1-aU5IdK8mn6MvmpZBZ_A_VAf3U
CitedBy_id crossref_primary_10_1039_D3NJ02067C
crossref_primary_10_1039_D2DT02455A
crossref_primary_10_1007_s10534_019_00172_w
crossref_primary_10_1007_s00775_023_02001_5
crossref_primary_10_1016_j_molliq_2023_122187
crossref_primary_10_1002_aoc_7459
crossref_primary_10_1007_s10812_022_01306_8
crossref_primary_10_3389_fphar_2022_1018951
crossref_primary_10_1016_j_jinorgbio_2020_111001
crossref_primary_10_1080_00958972_2018_1525488
Cites_doi 10.1016/S0022-328X(97)00303-3
10.1021/acs.chemrev.5b00597
10.1093/jnci/80.17.1373
10.1016/j.bcp.2014.08.006
10.1016/S0162-0134(01)00220-3
10.1080/15384101.2016.1211214
10.1039/b913896j
10.1016/j.jinorgbio.2003.08.014
10.1016/j.jinorgbio.2014.07.016
10.1039/C3DT52044G
10.1039/C5RA26071J
10.1039/C7RA00826K
10.1016/j.euf.2016.11.018
10.1038/nrc2167
10.1167/iovs.04-0279
10.1016/j.jinorgbio.2010.10.018
10.1016/j.canlet.2015.11.021
10.18632/oncotarget.13617
10.1016/j.jinorgbio.2014.03.004
10.2174/138955709789878169
10.1016/j.oraloncology.2016.04.003
10.1016/S0223-5234(02)01447-2
10.1016/S0277-5387(00)00473-3
10.1039/C6RA08063D
10.1016/j.jphotochem.2005.08.008
10.1021/cr980420v
10.1016/j.jinorgbio.2015.02.013
10.1016/j.talanta.2016.02.034
10.1021/jm400965m
10.1016/j.molstruc.2007.05.034
10.1016/j.bmc.2004.11.038
10.1667/RR2273.1
10.1016/j.pestbp.2006.05.003
10.1038/onc.2015.84
10.1016/j.ygyno.2013.04.019
10.1021/acs.jmedchem.6b00238
10.1016/S0079-6468(08)70259-5
10.1016/0277-5387(95)00298-7
ContentType Journal Article
DBID AAYXX
CITATION
7QO
8FD
FR3
P64
7SR
8BQ
JG9
DOI 10.1039/c7ra04443g
DatabaseName CrossRef
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Engineered Materials Abstracts
METADEX
Materials Research Database
DatabaseTitle CrossRef
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
Materials Research Database
Engineered Materials Abstracts
METADEX
DatabaseTitleList CrossRef
Engineering Research Database
Materials Research Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2046-2069
EndPage 26486
ExternalDocumentID 10_1039_C7RA04443G
GroupedDBID -JG
0-7
0R~
53G
AAEMU
AAFWJ
AAHBH
AAIWI
AAJAE
AARTK
AAWGC
AAXHV
AAYXX
ABASK
ABEMK
ABGFH
ABPDG
ABXOH
ACGFS
ADBBV
ADMRA
AEFDR
AENEX
AESAV
AETIL
AFLYV
AFPKN
AFVBQ
AGEGJ
AGRSR
AGSTE
AHGCF
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANBJS
ANUXI
APEMP
ASKNT
AUDPV
AUNWK
BCNDV
BLAPV
BSQNT
C6K
CITATION
EBS
ECGLT
EE0
EF-
EJD
GROUPED_DOAJ
H13
HZ~
H~N
J3G
J3H
J3I
M~E
O9-
OK1
PGMZT
R7C
R7G
RAOCF
RCNCU
ROYLF
RPM
RPMJG
RRC
RSCEA
RVUXY
SLH
SMJ
YAE
ZCN
7QO
8FD
FR3
P64
7SR
8BQ
JG9
ID FETCH-LOGICAL-c248g-22de9c61f801e229cbae54be331b9750741e085c5a190e3658b21450794e08113
ISSN 2046-2069
IngestDate Thu Jul 25 08:58:13 EDT 2024
Thu Jul 25 11:00:36 EDT 2024
Fri Aug 23 02:08:04 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 42
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c248g-22de9c61f801e229cbae54be331b9750741e085c5a190e3658b21450794e08113
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6824-2776
0000-0001-7267-7174
0000-0002-3102-5732
OpenAccessLink https://pubs.rsc.org/en/content/articlepdf/2017/ra/c7ra04443g
PQID 1906459688
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_1915322772
proquest_miscellaneous_1906459688
crossref_primary_10_1039_C7RA04443G
PublicationCentury 2000
PublicationDate 20170501
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 20170501
  day: 01
PublicationDecade 2010
PublicationTitle RSC advances
PublicationYear 2017
References Bandak (C7RA04443G-(cit3)/*[position()=1]) 2016
Zou (C7RA04443G-(cit38)/*[position()=1]) 2017; 7
Lovejoy (C7RA04443G-(cit9)/*[position()=1]) 2009
Brockman (C7RA04443G-(cit11)/*[position()=1]) 1956; 16
Jouad (C7RA04443G-(cit18)/*[position()=1]) 2001; 86
Miller 3rd (C7RA04443G-(cit13)/*[position()=1]) 1997; 18
He (C7RA04443G-(cit32)/*[position()=1]) 2005; 13
Johnstone (C7RA04443G-(cit1)/*[position()=1]) 2016; 116
Carcelli (C7RA04443G-(cit22)/*[position()=1]) 1997; 544
Holla (C7RA04443G-(cit19)/*[position()=1]) 2003; 38
Kelland (C7RA04443G-(cit7)/*[position()=1]) 2007; 7
Gandin (C7RA04443G-(cit41)/*[position()=1]) 2013; 56
Sheldrick (C7RA04443G-(cit24)/*[position()=1]) 1997
Spek (C7RA04443G-(cit25)/*[position()=1]) 1990; 46
Rades (C7RA04443G-(cit2)/*[position()=1]) 2016; 57
Wong (C7RA04443G-(cit6)/*[position()=1]) 1999; 99
Ghezzi (C7RA04443G-(cit26)/*[position()=1]) 2004; 98
Kunos (C7RA04443G-(cit15)/*[position()=1]) 2010; 174
Zhu (C7RA04443G-(cit5)/*[position()=1]) 2016; 35
Mohamed Subarkhan (C7RA04443G-(cit37)/*[position()=1]) 2016; 6
Toneatto (C7RA04443G-(cit27)/*[position()=1]) 2011; 105
Chandrasekher (C7RA04443G-(cit36)/*[position()=1]) 2004; 45
Rajarajeswari (C7RA04443G-(cit42)/*[position()=1]) 2014; 140
Shao (C7RA04443G-(cit20)/*[position()=1]) 2014; 43
Bolattin (C7RA04443G-(cit31)/*[position()=1]) 2016; 6
Shao (C7RA04443G-(cit39)/*[position()=1]) 2014; 136
Sun (C7RA04443G-(cit35)/*[position()=1]) 2016; 15
Agrawal (C7RA04443G-(cit12)/*[position()=1]) 1978; 15
Hordge (C7RA04443G-(cit30)/*[position()=1]) 2016; 152
Zhang (C7RA04443G-(cit10)/*[position()=1]) 2009; 9
Li (C7RA04443G-(cit40)/*[position()=1]) 2015; 146
Kunos (C7RA04443G-(cit14)/*[position()=1]) 2013; 130
Kandagal (C7RA04443G-(cit28)/*[position()=1]) 2006; 179
Ishiguro (C7RA04443G-(cit16)/*[position()=1]) 2014; 91
Loehrer (C7RA04443G-(cit8)/*[position()=1]) 1988; 80
Stacy (C7RA04443G-(cit17)/*[position()=1]) 2016; 59
Wang (C7RA04443G-(cit29)/*[position()=1]) 2008; 875
Zhang (C7RA04443G-(cit33)/*[position()=1]) 2007; 87
Xiao (C7RA04443G-(cit4)/*[position()=1]) 2017; 8
West (C7RA04443G-(cit23)/*[position()=1]) 1996; 15
Castiñeiras (C7RA04443G-(cit21)/*[position()=1]) 2000; 19
Seo (C7RA04443G-(cit34)/*[position()=1]) 2016; 371
References_xml – volume: 544
  start-page: 29
  year: 1997
  ident: C7RA04443G-(cit22)/*[position()=1]
  publication-title: J. Organomet. Chem.
  doi: 10.1016/S0022-328X(97)00303-3
  contributor:
    fullname: Carcelli
– volume: 116
  start-page: 3436
  year: 2016
  ident: C7RA04443G-(cit1)/*[position()=1]
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.5b00597
  contributor:
    fullname: Johnstone
– volume: 80
  start-page: 1373
  year: 1988
  ident: C7RA04443G-(cit8)/*[position()=1]
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/80.17.1373
  contributor:
    fullname: Loehrer
– volume: 91
  start-page: 312
  year: 2014
  ident: C7RA04443G-(cit16)/*[position()=1]
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2014.08.006
  contributor:
    fullname: Ishiguro
– volume: 86
  start-page: 565
  year: 2001
  ident: C7RA04443G-(cit18)/*[position()=1]
  publication-title: J. Inorg. Biochem.
  doi: 10.1016/S0162-0134(01)00220-3
  contributor:
    fullname: Jouad
– volume: 15
  start-page: 2647
  year: 2016
  ident: C7RA04443G-(cit35)/*[position()=1]
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2016.1211214
  contributor:
    fullname: Sun
– start-page: 10651
  year: 2009
  ident: C7RA04443G-(cit9)/*[position()=1]
  publication-title: Dalton Trans.
  doi: 10.1039/b913896j
  contributor:
    fullname: Lovejoy
– volume: 98
  start-page: 73
  year: 2004
  ident: C7RA04443G-(cit26)/*[position()=1]
  publication-title: J. Inorg. Biochem.
  doi: 10.1016/j.jinorgbio.2003.08.014
  contributor:
    fullname: Ghezzi
– volume: 140
  start-page: 255
  year: 2014
  ident: C7RA04443G-(cit42)/*[position()=1]
  publication-title: J. Inorg. Biochem.
  doi: 10.1016/j.jinorgbio.2014.07.016
  contributor:
    fullname: Rajarajeswari
– volume: 43
  start-page: 1663
  year: 2014
  ident: C7RA04443G-(cit20)/*[position()=1]
  publication-title: Dalton Trans.
  doi: 10.1039/C3DT52044G
  contributor:
    fullname: Shao
– volume: 6
  start-page: 25082
  year: 2016
  ident: C7RA04443G-(cit37)/*[position()=1]
  publication-title: RSC Adv.
  doi: 10.1039/C5RA26071J
  contributor:
    fullname: Mohamed Subarkhan
– volume: 7
  start-page: 17923
  year: 2017
  ident: C7RA04443G-(cit38)/*[position()=1]
  publication-title: RSC Adv.
  doi: 10.1039/C7RA00826K
  contributor:
    fullname: Zou
– year: 2016
  ident: C7RA04443G-(cit3)/*[position()=1]
  publication-title: Eur. Urol. Focus
  doi: 10.1016/j.euf.2016.11.018
  contributor:
    fullname: Bandak
– volume: 7
  start-page: 573
  year: 2007
  ident: C7RA04443G-(cit7)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2167
  contributor:
    fullname: Kelland
– volume: 45
  start-page: 3577
  year: 2004
  ident: C7RA04443G-(cit36)/*[position()=1]
  publication-title: Invest. Ophthalmol. Visual Sci.
  doi: 10.1167/iovs.04-0279
  contributor:
    fullname: Chandrasekher
– volume: 105
  start-page: 645
  year: 2011
  ident: C7RA04443G-(cit27)/*[position()=1]
  publication-title: J. Inorg. Biochem.
  doi: 10.1016/j.jinorgbio.2010.10.018
  contributor:
    fullname: Toneatto
– volume: 371
  start-page: 30
  year: 2016
  ident: C7RA04443G-(cit34)/*[position()=1]
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2015.11.021
  contributor:
    fullname: Seo
– volume: 8
  start-page: 1329
  year: 2017
  ident: C7RA04443G-(cit4)/*[position()=1]
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.13617
  contributor:
    fullname: Xiao
– volume: 136
  start-page: 13
  year: 2014
  ident: C7RA04443G-(cit39)/*[position()=1]
  publication-title: J. Inorg. Biochem.
  doi: 10.1016/j.jinorgbio.2014.03.004
  contributor:
    fullname: Shao
– volume: 9
  start-page: 1357
  year: 2009
  ident: C7RA04443G-(cit10)/*[position()=1]
  publication-title: Mini-Rev. Med. Chem.
  doi: 10.2174/138955709789878169
  contributor:
    fullname: Zhang
– volume: 57
  start-page: 40
  year: 2016
  ident: C7RA04443G-(cit2)/*[position()=1]
  publication-title: Oral Oncol.
  doi: 10.1016/j.oraloncology.2016.04.003
  contributor:
    fullname: Rades
– volume: 38
  start-page: 313
  year: 2003
  ident: C7RA04443G-(cit19)/*[position()=1]
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/S0223-5234(02)01447-2
  contributor:
    fullname: Holla
– volume: 19
  start-page: 1873
  year: 2000
  ident: C7RA04443G-(cit21)/*[position()=1]
  publication-title: Polyhedron
  doi: 10.1016/S0277-5387(00)00473-3
  contributor:
    fullname: Castiñeiras
– volume: 6
  start-page: 63463
  year: 2016
  ident: C7RA04443G-(cit31)/*[position()=1]
  publication-title: RSC Adv.
  doi: 10.1039/C6RA08063D
  contributor:
    fullname: Bolattin
– volume: 179
  start-page: 161
  year: 2006
  ident: C7RA04443G-(cit28)/*[position()=1]
  publication-title: J. Photochem. Photobiol., A
  doi: 10.1016/j.jphotochem.2005.08.008
  contributor:
    fullname: Kandagal
– volume: 99
  start-page: 2451
  year: 1999
  ident: C7RA04443G-(cit6)/*[position()=1]
  publication-title: Chem. Rev.
  doi: 10.1021/cr980420v
  contributor:
    fullname: Wong
– volume: 16
  start-page: 167
  year: 1956
  ident: C7RA04443G-(cit11)/*[position()=1]
  publication-title: Cancer Res.
  contributor:
    fullname: Brockman
– volume: 146
  start-page: 52
  year: 2015
  ident: C7RA04443G-(cit40)/*[position()=1]
  publication-title: J. Inorg. Biochem.
  doi: 10.1016/j.jinorgbio.2015.02.013
  contributor:
    fullname: Li
– start-page: 1600
  year: 1997
  ident: C7RA04443G-(cit24)/*[position()=1]
  publication-title: Acta Crystallogr., Sect. E: Struct. Rep. Online
  contributor:
    fullname: Sheldrick
– volume: 152
  start-page: 401
  year: 2016
  ident: C7RA04443G-(cit30)/*[position()=1]
  publication-title: Talanta
  doi: 10.1016/j.talanta.2016.02.034
  contributor:
    fullname: Hordge
– volume: 56
  start-page: 7416
  year: 2013
  ident: C7RA04443G-(cit41)/*[position()=1]
  publication-title: J. Med. Chem.
  doi: 10.1021/jm400965m
  contributor:
    fullname: Gandin
– volume: 875
  start-page: 509
  year: 2008
  ident: C7RA04443G-(cit29)/*[position()=1]
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2007.05.034
  contributor:
    fullname: Wang
– volume: 13
  start-page: 1837
  year: 2005
  ident: C7RA04443G-(cit32)/*[position()=1]
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2004.11.038
  contributor:
    fullname: He
– volume: 174
  start-page: 574
  year: 2010
  ident: C7RA04443G-(cit15)/*[position()=1]
  publication-title: Radiat. Res.
  doi: 10.1667/RR2273.1
  contributor:
    fullname: Kunos
– volume: 87
  start-page: 23
  year: 2007
  ident: C7RA04443G-(cit33)/*[position()=1]
  publication-title: Pestic. Biochem. Physiol.
  doi: 10.1016/j.pestbp.2006.05.003
  contributor:
    fullname: Zhang
– volume: 18
  start-page: 4131
  year: 1997
  ident: C7RA04443G-(cit13)/*[position()=1]
  publication-title: Anticancer Res.
  contributor:
    fullname: Miller 3rd
– volume: 35
  start-page: 323
  year: 2016
  ident: C7RA04443G-(cit5)/*[position()=1]
  publication-title: Oncogene
  doi: 10.1038/onc.2015.84
  contributor:
    fullname: Zhu
– volume: 130
  start-page: 75
  year: 2013
  ident: C7RA04443G-(cit14)/*[position()=1]
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2013.04.019
  contributor:
    fullname: Kunos
– volume: 59
  start-page: 4965
  issue: 10
  year: 2016
  ident: C7RA04443G-(cit17)/*[position()=1]
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.6b00238
  contributor:
    fullname: Stacy
– volume: 15
  start-page: 321
  year: 1978
  ident: C7RA04443G-(cit12)/*[position()=1]
  publication-title: Prog. Med. Chem.
  doi: 10.1016/S0079-6468(08)70259-5
  contributor:
    fullname: Agrawal
– volume: 46
  start-page: c34
  year: 1990
  ident: C7RA04443G-(cit25)/*[position()=1]
  publication-title: Acta Crystallogr., Sect. A: Found. Crystallogr.
  contributor:
    fullname: Spek
– volume: 15
  start-page: 665
  year: 1996
  ident: C7RA04443G-(cit23)/*[position()=1]
  publication-title: Polyhedron
  doi: 10.1016/0277-5387(95)00298-7
  contributor:
    fullname: West
SSID ssj0000651261
Score 2.2356725
Snippet Three thiosemicarbazone-based platinum( ii ) complexes [Pt(MH-TSC)Cl] ( 1 ), [Pt(ME-TSC)Cl] ( 2 ) and [Pt(NH-TSC) 2 ]Cl ( 3 ) (MH-TSC = ( E...
Three thiosemicarbazone-based platinum(ii) complexes [Pt(MH-TSC)Cl] (1), [Pt(ME-TSC)Cl] (2) and [Pt(NH-TSC)2]Cl (3) (MH-TSC =...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 26478
SubjectTerms Apoptosis
Biotechnology
Cancer
Fluorescence
Ligands
Synthesis
Toxicity
Tryptophan
Title Three Pt( ii ) complexes based on thiosemicarbazone: synthesis, HSA interaction, cytotoxicity, apoptosis and cell cycle arrest
URI https://search.proquest.com/docview/1906459688
https://search.proquest.com/docview/1915322772
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5Be4AL4inKo1oEB1DiEq_f3CLTNkKhVGkCLhfLux6nvtiRH1JT8eOZXceOKypUuFjRyrI2O59mvpnd-ZaQd5ERx6YOXBN67Gpm4tmaZ-EDHAv0BEwv8WRz8tcTe7IwvwRW0Nsxld0lFT8QVzf2lfyPVXEM7Sq7ZP_Bst1HcQB_o33xiRbG5y1tXAAMTtGPumkq83t1QBwuoRzI6BQ3OwFpXipRgIJHV3mmetHLdYbEr2z0BSZnY6UaUTQ9DnJIrKu8yi9TsbkzIFrlqyqX2iWqDU7W-8QaJzOI1N0efYY7O_PbgwUdXZ82QgVBrX3ON5FSjdYqAETapDcaNBsm_gVkS-3nRbottaqi7g9IteM67xcrMAB2RwMPQDk1hvk42rC5nqX1wE4PaI3WVutOZSdsLzbL43j2jY5_ZEjdVOEUkRTAM5bb8NZu6Z98C48W02k4Pwzmd8kuczwLk_Xd2fdFcN5V5ZCQ6ZhTtjq2hvdx-8nrzOV64FZsZP6QPNikEXTcYOIRuQPZY3LPb2_ve0J-KWzQ0-p9mn6gHS6owgXNM_oHLj7RDhVDipigPUwMaR8RQ9rhgSIeqMQDVXigDR6eksXR4dyfaJubNjTBTHepMRaDJ2w9Qb4CjHmCR2CZHAxD5x5ySqSdgNxcWBHyRzCQtXKpcD9CZ47jum48IzsZzvQ5oRDrbmJj4NBNbsY2jyzD4cxFnixGLDGdPfK2XcVw1QiqhOoghOGFvjMbq7U-3iNv2gUOceHk_4gyyOsyxAlI_SPbdf_2DsZxxjBxfHGLd16S-1uoviI7VVHDa2SaFd9XFZr9DUh-A_uPhGQ
link.rule.ids 315,786,790,870,27957,27958
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Three+Pt%28ii%29+complexes+based+on+thiosemicarbazone%3A+synthesis%2C+HSA+interaction%2C+cytotoxicity%2C+apoptosis+and+cell+cycle+arrest&rft.jtitle=RSC+advances&rft.au=Lin%2C+Xu-Dong&rft.au=Liu%2C+Ya-Hong&rft.au=Xie%2C+Cheng-Zhi&rft.au=Bao%2C+Wei-Guo&rft.date=2017-05-01&rft.eissn=2046-2069&rft.volume=7&rft.issue=42&rft.spage=26478&rft.epage=26486&rft_id=info:doi/10.1039%2Fc7ra04443g&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-2069&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-2069&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-2069&client=summon